330 likes | 472 Views
Risk Assessment of GM Plants. Assoc. Prof. Dr. Wichai Cherdshewasart Department of Biology, Faculty of Science, Chulalongkorn University Tel 02-2185033 Fax 02-2185034. Modes of plant gene modification. 1. Classical breeding (wild crossing) 2. Mutation 3. Somaclonal variation
E N D
Risk Assessment of GM Plants Assoc. Prof. Dr. Wichai Cherdshewasart Department of Biology, Faculty of Science, Chulalongkorn UniversityTel 02-2185033 Fax 02-2185034
Modes of plant gene modification 1. Classical breeding (wild crossing) 2. Mutation 3. Somaclonal variation 4. Protoplast fusion 5. Embryo rescue 6. Gene transfer
1. Classical breeding (wild crossing) • Advantage: practical, low cost, stable, effective within species • Disadvantage: time-consumed, ineffective within different species
2. Mutation • Advantage: practical, low cost • Disadvantage: randomized, needs long selection procedure, not totally stable, may initiate revertant
3. Somaclonal variation • Advantage: in vitro manipulation • Disadvantage: takes time, randomized, needs long selection procedure
4. Protoplast fusion • Advantage: across species barrier • Disadvantage: randomized, remote species may success but fail for further development
5. Embryo rescue • Advantage: cross between different species is possible to initiate embryonic development. • Disadvantage: transfer pre-mature embryo to new environment could initiate fully developed plants, but sterile
6. Gene transfer • Advantage: precise genotype obtained, laboratory and industry practical • Disadvantage: Not possible for all species, especially monocot
Mode of gene transfer: 1. Vector-mediated gene transfer • Agrobacterium-mediated • Virus-mediated 2. Vectorless-mediated gene transfer (Direct gene transfer) • Mechanical • Physical • Electrical • Chemical
Analysis of transgenic plants 1. Phenotypic analysis 2. Genotypic analysis 3. Greenhouse condition analysis 4. Field trial condition analysis
Genotypic analysis • PCR for rapid screening • Southern blot for precise gene detection • Northern blot for transcription analysis • Western blot for translation analysis, together with Ab-binding or enzymatic analysis • Mendelian analysis for insertion locus and linkage analysis • In situ hybridization for precise insertion locus analysis • DNA methylationanalysis for silencing potential analysis
A generally accepted risk assessment method*,**,*** 1. Identify potential adverse effects on human health and/or the environment 2. Estimate the likelihood of these adverse effects being realized 3. Evaluate the consequence should be identified effects be realized (the risk) 4. Consider appropriate risk-management strategies 5. Estimate the overall potential impact, including a consideration of potential impacts that may be beneficial to human health or the environment * UNEP International Technical Guideline for Safety in Biotechnology ** The Cartegena Protocol *** EC Directive 2001/18/EEC
Approaches to risk assessment 1.Trait analysis • characteristics of the modified organism; transgene, parental organisms, receiving environment • less problem, if small scale • more problem, if large scale 2.Familarity • comparison of transgenic to similar organism(s) derived from classical genetic methods • assume that small genetic changes (1-4 genes) exhibits no significant change in well-known organism, phenotype is still the same
3.Formulaic • possible adverse effects; to human health or the environment • R = H x E • R; Risk, H; Hazard, E; Exposure • facilitates consideration of risk-management options 4.Intuitive Reasoning • use education, experience and reason to promote knowledge for making decision with complete information • depends on what should be considered • use of expert committees, independent reviewers/assessors without a conflict of interest
Needs: 1. Environmental friendly products 2. Tight global regulatory requirements 3. Trade barrier • Methods: 1. Product and country specification 2. Science-based assessment 3. Multi-tiered, complementary approaches
Plant assessment: 1. Survival against wild type plants 2. Stability of gene expression, especially in the field vs. laboratory / greenhouse 3. Distinct genotype over wild type plant 4. Invasiveness of transgenic plants, the possibility to develop into weeds
Trait assessment: 1. Toxicity to non-target organisms 2. In case of human consumption, no allergen / toxic substance 3. Ecological impacts (outcrossing)
Regulatory principles: • Scientifically based, based on information of organism, used technology and effects to humans and environment • Product-based approach, use existing product-based legislation • Familiarity and substantial equivalence, experience with the use of that species. The determination is based on scientific literature and practical experience with the plant and similar plant varieties. • Case-by case, allow the development of knowledge that could inform criteria and requirement over time.
Regulatory principles: • Step-wise fashion, products should be assessed throughout the chain of development : From laboratory to greenhouse and finally large-scale field trial • Transparency • Precautionary principle/approach, derived from Rio Declaration, regulatory groups can make decisions about products based on scientific uncertainty. • Harmonization, sharing of or acceptance of another group’s review
1. Good laboratory practice • Tightly control of GM-vectors, plasmids and plant materials • Apply no bacterial antibiotic resistant-derived gene • Apply bioluminescence gene from animal as marker • Apply antisense for pollen developmental gene • Limit level of toxic gene, eg, cry family
2. Good agricultural practice • Controlled plantation area with standard buffer zone and % sharing with wild type plants • Emasculation • Flower bud elimination • Closed-bag control • Net protection of fruits and seeds from insects, birds, bats, rodents • Total fruit and seed collection • Labeling and separation technique for transgenic plant and seed • Whole plant elimination after harvest
3. Good manufacturing practice • Labeling GM-products according to domestic and export regulations • Testing for allergen and toxicity of the products containing GM-materials
4. Good marketing practice • Fully-informed alien gene(s) and awareness of application • Evaluated for allergen and toxic molecule • Labeling • Post marketing record
5. Good consumption practice • For GM-food products: determine animals as primary consumer and human as secondary consumer • Study labeling • Food safety criteria
References • Head G. and Duan J. 2002. Environmental safety assessment for transgenic crops. • Wolf K. 1994. Gene transfer between organelles and the nucleus in lower eukaryotes • Copy P. Bazin C. Anxolabehere D. Langin T. 1994. Horizontal transfer and the evolution of transposable elements • Landmann J. Graser E. Riedel-Preuss A. van der Hoeven C. 1994. Can Agrobacteria be eliminated from transgenic plants? • Hoffmann T. Golz C. Schieder O. 1994. Preliminary findings of DNA transfer from transgenic plants to a wild-type strain of Aspergillus niger • Hansen L. C. Obryeki J.-J. L. 2000 Field deposition of Bt transgeniccorn pollen: lethal effects on the monarch butterfly.